Acinetobacter Baumannii News and Research

RSS
New portable adhesive patch drives small electrical current to promote wound healing

New portable adhesive patch drives small electrical current to promote wound healing

Knocking out genes in E. coli affects stiffness, integrity of bacterial envelope

Knocking out genes in E. coli affects stiffness, integrity of bacterial envelope

Tiny molecular scaffolding could be key to fight against antibiotic resistance

Tiny molecular scaffolding could be key to fight against antibiotic resistance

Novel method uses light-activated nanodrug to help fight antibiotic-resistant infections

Novel method uses light-activated nanodrug to help fight antibiotic-resistant infections

Anti-biofilm compounds show promise against drug-resistant bacteria associated with hospital-acquired infections

Anti-biofilm compounds show promise against drug-resistant bacteria associated with hospital-acquired infections

Naturally occurring clay exhibits potent antibacterial activity against ESKAPE pathogens

Naturally occurring clay exhibits potent antibacterial activity against ESKAPE pathogens

Carbapenem-resistant Enterobacteriaceae: an interview with Dr. Michael Dudley

Carbapenem-resistant Enterobacteriaceae: an interview with Dr. Michael Dudley

Antivirulence antibiotics could evade resistance longer than traditional antibiotics

Antivirulence antibiotics could evade resistance longer than traditional antibiotics

New Locilex microbiology data presented at ICAAC/ICC 2015 scientific conference

New Locilex microbiology data presented at ICAAC/ICC 2015 scientific conference

Combination of TXA709 and cefdinir demonstrates synergistic antibacterial activity against MRSA

Combination of TXA709 and cefdinir demonstrates synergistic antibacterial activity against MRSA

Aridis' AR-301 granted FDA Fast Track Designation for treatment of pneumonia caused by S. aureus

Aridis' AR-301 granted FDA Fast Track Designation for treatment of pneumonia caused by S. aureus

Multidrug-resistant bacteria can naturally relinquish its ability to resist antibiotics

Multidrug-resistant bacteria can naturally relinquish its ability to resist antibiotics

Aridis expands, accelerates current AR-301 Phase 2a study for treatment of acute pneumonia in the U.S.

Aridis expands, accelerates current AR-301 Phase 2a study for treatment of acute pneumonia in the U.S.

Aridis' Aerucin gets FDA Fast Track Designation for treatment of hospital-acquired and ventilator-associated pneumonia

Aridis' Aerucin gets FDA Fast Track Designation for treatment of hospital-acquired and ventilator-associated pneumonia

Common antibiotic azithromycin effectively kills many multidrug-resistant bacteria

Common antibiotic azithromycin effectively kills many multidrug-resistant bacteria

TAXIS Pharmaceuticals' TXA709 compound shows promise in combating antibiotic resistance

TAXIS Pharmaceuticals' TXA709 compound shows promise in combating antibiotic resistance

NIAID funds nine research projects to advance rapid diagnostics tests for drug-resistant bacteria

NIAID funds nine research projects to advance rapid diagnostics tests for drug-resistant bacteria

Aridis Pharmaceuticals begins Aerucin Phase 1 clinical study for treatment of acute pneumonia

Aridis Pharmaceuticals begins Aerucin Phase 1 clinical study for treatment of acute pneumonia

New NIH grant to support development of rapid method for diagnosing mucormycosis

New NIH grant to support development of rapid method for diagnosing mucormycosis

Antibiotic stewardship programs reduce hospital readmissions due to infection

Antibiotic stewardship programs reduce hospital readmissions due to infection